Epidemiological Characterization of Opportunistic Mycoses between the Years 2006 and 2010 in Korea |
Park, Je-Seop
(Department of Biomedical Laboratory Science, College of Medical Science, Konyang University)
Cho, Seung-Hak (Division of Enteric Diseases, Center for Infectious Diseases, Korea National Institute of Health) Youn, Seung-Ki (Division of Quarantine Support, Korea Centers for Disease Control and Prevention) Bak, Young-Seok (Department of Emergency Medical Service, College of Medical Science, Konyang University) Yu, Young-Bin (Department of Biomedical Laboratory Science, College of Medical Science, Konyang University) Kim, Young Kwon (Department of Biomedical Laboratory Science, College of Medical Science, Konyang University) |
1 | Ambrosioni J, Bouchuiguir-Wafa K, Garbino J. 2010. Emerging invasive zygomycosis in a tertiary care center: epidemiology and associated risk factors. Int. J. Infect. Dis. 14: e100-e103. DOI |
2 | Auberger J, Lass-Flörl C, Ulmer H, Nogler-Semenitz E, Clausen J, Gunsilius E, et al. 2008. Significant alterations in the epidemiology and treatment outcome of invasive fungal infections in patients with hematological malignancies. Int. J. Hematol. 88: 508-515. DOI |
3 | Colombo AL, Nucci M, Park BJ, Nouér SA, Arthington-Skaggs B, da Matta DA, et al. 2006. Epidemiology of candidemia in Brazil: a nationwide sentinel surveillance of candidemia in eleven medical centers. J. Clin. Microbiol. 44: 2816-2823. DOI |
4 | Gonzalez GM, Elizondo M, Ayala J. 2008. Trends in species distribution and susceptibility of bloodstream isolates of Candida collected in Monterrey, Mexico, to seven antifungal agents: results of a 3-year (2004 to 2007) surveillance study. J. Clin. Microbiol. 46: 2902-2905. DOI |
5 | Denning DW. 1996. Therapeutic outcome in invasive aspergillosis. Clin. Infect. Dis. 23: 608-615. DOI |
6 | Eggimann P, Garbino J, Pittet D. 2003. Epidemiology of Candida species infection in critically ill non-immunosuppressed patients. Lancet Infect. Dis. 3: 685-702. DOI |
7 | Garnacho-Montero J, Amaya-Villar R, Ortiz-Leyba C, León C, Alvarez-Lerma F, Nolla-Salas J, et al. 2005. Isolation of Aspergillus spp. from the respiratory tract in critically ill patients: risk factors, clinical presentation and outcome. Crit. Care 9: R191-R199. DOI |
8 | Gudlaugsson O, Gillespie S, Lee K, Vande Berg J, Hu J, Messer S, et al. 2003. Attributable mortality of nosocomial candidemia, revised. Clin. Infect. Dis. 37: 1172-1177. DOI |
9 | Hajjeh RA, Sofair AN, Harrison LH, Lyon GM, Arthington-Skaggs BA, Mirza SA, et al. 2004. Incidence of bloodstream infections due to Candida species and in vitro susceptibilities of isolates collected from 1998 to 2000 in a population-based active surveillance program. J. Clin. Microbiol. 42: 1519-1527. DOI |
10 | Hoang LM, Maquire JA, Doyle P, Fyfe M, Roscoe DL. 2004. Cryptococcus neoformans infections at Vancouver Hospital and Health Sciences Centre (1997–2002): epidemiology, microbiology and histopathology. J. Med. Microbiol. 53: 935-940. DOI |
11 | Jain A, Jain S, Rawar S. 2010. Emerging fungal infections among children: a review on its clinical manifestations, diagnosis, and prevention. J. Pharm. Bioallied Sci. 2: 314-320. DOI |
12 | Kontoyiannis DP, Marr KA, Park BJ, Alexander BD, Anaissie EJ, Walsh TJ, et al. 2010. Prospective surveillance for invasive fungal infections in hematopoietic stem cell transplant recipients, 2001-2006: overview of the Transplant-Associated Infection Surveillance Network (TRANSNET) Database. Clin. Infect. Dis. 50: 1091-1100. DOI |
13 | Marr KA, Carter RA, Crippa F, Wald A, Corey L. 2002. Epidemiology and outcome of mould infections in hematopoietic stem cell transplant recipients. Clin. Infect. Dis. 34: 909-917. DOI |
14 | Javis WR. 1995. Epidemiology of nosocomial fungal infections, with emphasis on Candida species. Clin. Infect. Dis. 20: 1526-1530. DOI |
15 | Kauffman CA. 2004. Zygomycosis: reemergence of an old pathogen. Clin. Infect. Dis. 39: 588-590. DOI |
16 | McNeil MM, Nash SL, Hajjeh RA, Phelan MA, Conn LA, Plikaytis BD, Warnock DW. 2001. Trends in mortality due to invasive mycotic diseases in the United States, 1908-1997.Clin. Infect. Dis. 33: 641-647. DOI |
17 | Meis JF, Chakrabarti A. 2009. Changing epidemiology of an emerging infection: zygomycosis. Clin. Microbiol. Infect. 15: 10-14. DOI |
18 | Morgan J, Meltzer MI, Plikaytis BD, Sofair AN, Huie-White S, Wilcox S, et al. 2005. Excess mortality, hospital stay, and cost due to candidemia: a case-control study using data from population-based candidemia surveillance. Infect. Control Hosp. Epidemiol. 26: 540-547. DOI |
19 | Nucci M, Queiroz-Telles F, Tobón AM, Restrepo A, Colombo AL. 2010. Epidemiology of opportunistic fungal infections in Latin America. Clin. Infect. Dis. 51: 561-570. DOI |
20 | Pappas PG, Rex JH, Lee J, Hamill RJ, Larsen RA, Powderly W, et al. 2003. A prospective observational study of candidemia: epidemiology, therapy, and influences on mortality in hospitalized adult and pediatric patients. Clin. Infect. Dis. 37: 634-643. DOI |
21 | Pfaller MA. 2004. An epidemiologic update on invasive fungal infections. Adv. Stud. Med. 4: S269-S275. |
22 | Patterson TF, Kirkpatrick WR, White M, Hiemenz JW, Wingard JR, Dupont B, et al. 2000. Invasive aspergillosis. Disease spectrum, treatment practices, and outcomes. I3 Aspergillus Study Group. Medicine 79: 250-260. DOI |
23 | Perfect JR, Cox GM, Lee JY, Kauffman CA, de Repentigny L, Chapman SW, et al. 2001. The impact of culture isolation of Aspergillus species: a hospital-based survey of aspergillosis. Clin. Infect. Dis. 33: 1824-1833. DOI |
24 | Perusquía-Ortiz AM, Vázquez-González D, Bonifaz A. 2012. Opportunistic filamentous mycoses: aspergillosis, mucormycosis, phaeohyphomycosis and hyalohyphomycosis. J. Dtsch. Dermatol. Ges. 10: 611-621. |
25 | Pfaller MA, Pappas PG, Wingard JR. 2006. Invasive fungal pathogens: current epidemiological trends. Clin. Infect. Dis. 43: S3-S14. DOI |
26 | Puzniak L, Teutsch S, Powderly W, Polish L. 2004. Has the epidemiology of nosocomial candidemia changed?. Infect. Control Hosp. Epidemiol. 25: 628-633. DOI |
27 | Ribes JA, Vanover-Sams CL, Baker DJ. 2000. Zygomycetes in human disease. Clin. Microbiol. Rev. 13: 236-301. DOI |
28 | Roden MM, Zaoutis TE, Buchanan WL, Knudsen TA, Sarkisova TA, Schaufele RL, et al. 2005. Epidemiology and outcome of zygomycosis: a review of 929 reported cases. Clin. Infect. Dis. 41: 634-653. DOI |
29 | Slavin M, Fastenau J, Sukarom I, Marvos P, Crowley S, Gerth WC. 2004. Burden of hospitalization of patients with Candida and Aspergillus infections in Australia. Int. J. Infect. Dis. 8: 111-120. DOI |
30 | Warnock DW, Hajjeh RA, Lasker BA. 2001. Epidemiology and prevention of invasive aspergillosis. Curr. Infect. Dis. Rep. 3: 507-516. DOI |
31 | Zaoutis TE, Argon J, Chu J, Berlin JA, Walsh TJ, Feudtner C. 2005. The epidemiology and attributable outcomes of candidemia in adults and children hospitalized in the United States: a propensity analysis. Clin. Infect. Dis. 41: 1232-1239. DOI |
32 | Warnock DW. 2007. Trends in the epidemiology of invasive fungal infections. Jpn. J. Med. Mycol. 48: 1-12. DOI |
33 | Wenzel RP, Gennings C. 2005. Bloodstream infections due to Candida species in the intensive care unit: identifying especially high-risk patients to determine prevention strategies. Clin. Infect. Dis. 41: S389-S393. DOI |
34 | Yamazaki T, Kume H, Murase S, Yamashita E, Arisawa M. 1999. Epidemiology of visceral mycoses: analysis of data in annual of the pathological autopsy cases in Japan. J. Clin. Microbiol. 37: 1732-1738. |
35 | Zilberberg MD, Shorr AF, Kollef MH. 2008. Secular trends in candidemia-related hospitalization in the United States, 2000–2005. Infect. Control Hosp. Epidemiol. 29: 978-980 DOI |